Auto-login on future visits

Forgot your password?

Register for an account

What is AMD?

The Facts

A worsening problem

AMD is the leading cause of age-related blindness in the developed world. Recent figures demonstrate that, in the developed world, AMD accounts for over 50% of cases of registered blindness. 

Because we are living longer, and because of the growing world population, the number of people suffering from AMD is expected to double by 2020.

The cost of AMD

There is treatment for AMD in the form of injections into the eye; however, this is only for select cases of late-stage AMD, and there is an extremely short window of opportunity (a couple of weeks). Each injection costs up to €4,000 (= US $ 5,168), and there must be at least six such injections per year.

Age-related macular degeneration (AMD) is a disease of the macula, the central part of the retina in the eye, that results in loss of central vision.

There are two types of AMD: early and late. Early AMD can be present in the eye without the sufferer being aware of it, as it has no symptoms that can be detected by the human eye. There are signs, however, that an eyecare professional can identify by using specialised equipment. Early AMD progresses into late AMD, and this becomes visually consequential; in order words, it affects vision. The earlier AMD is diagnosed, the easier it is to intervene.